Molecular structure of Dexamethasone Sodium Phosphate, CAS Number: 2392-39-4
Dexamethasone Sodium Phosphate (CAS 2392-39-4)
See product citations (7)
Alternate Names:
(11b, 16a)-9-Fluoro-11,17,21-trihydroxy-16- methylpregna-1,4-diene-3,20-dione 21-phosphate disodium salt; Dexamethasone 21-Phosphate Disodium Salt; Ak-Dex; Baldex; Dalalone; Dezone; Hexadrol; Oradexon; Soldesam
Application:
Dexamethasone Sodium Phosphate is an inducer of apoptosis and inhibitor of the sodium phosphate symporter
CAS Number:
2392-39-4
Purity:
≥98%
Molecular Weight:
516.4
Molecular Formula:
C22H28FO8P•2Na
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Dexamethasone Sodium Phosphate is a systemic corticosteroid. Dexamethasone Sodium Phosphate induces apoptosis and inhibits sodium phosphate symporter. Dexamethasone Sodium Phosphate is also used in the treatment of emetic effects of cancer therapy and epicondylitis. Dexamethasone Sodium Phosphate is an activator of GR.
Dexamethasone Sodium Phosphate (CAS 2392-39-4) References
- [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1]. | Chen, Y. and Chen, XY. 2002. Ai Zheng. 21: 498-503. PMID: 12452040
- Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis. A randomized, double-blinded, placebo-controlled study. | Nirschl, RP., et al. 2003. Am J Sports Med. 31: 189-95. PMID: 12642251
- Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. | Hayreh, SS. and Zimmerman, B. 2003. Ophthalmology. 110: 1204-15. PMID: 12799248
- [Using chamber technique for studying the permeability of dexamethasone sodium phosphate liposome through rabbit colon mucosa in vitro]. | Li, GF., et al. 2004. Di Yi Jun Yi Da Xue Xue Bao. 24: 11-4. PMID: 14724084
- Stability of dexamethasone sodium phosphate in rat plasma. | Samtani, MN. and Jusko, WJ. 2005. Int J Pharm. 301: 262-6. PMID: 16054309
- Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation. | Saari, KM., et al. 2006. Graefes Arch Clin Exp Ophthalmol. 244: 620-6. PMID: 16217662
- Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography/tandem mass spectrometry. | Zhang, M., et al. 2011. J Chromatogr B Analyt Technol Biomed Life Sci. 879: 17-24. PMID: 21112257
- Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. | Bird, PA., et al. 2011. Otol Neurotol. 32: 933-6. PMID: 21725263
- Stability-Indicating HPLC Method for Simultaneous Determination of Chloramphenicol, Dexamethasone Sodium Phosphate and Tetrahydrozoline Hydrochloride in Ophthalmic Solution. | AlAani, H. and Alnukkary, Y. 2016. Adv Pharm Bull. 6: 137-41. PMID: 27123429
- Calcium ion cross-linking alginate/dexamethasone sodium phosphate hybrid hydrogel for extended drug release. | Zhang, R., et al. 2019. Colloids Surf B Biointerfaces. 175: 569-575. PMID: 30580147
- Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization. | Wang, B., et al. 2019. Nanomedicine. 17: 119-123. PMID: 30677499
- Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system. | Akrami-Hasan-Kohal, M., et al. 2021. Colloids Surf B Biointerfaces. 205: 111892. PMID: 34107443
- Environmental Risk Assessment of Dexamethasone Sodium Phosphate and Tocilizumab Mixture in Zebrafish Early Life Stage (Danio rerio). | Di Paola, D., et al. 2022. Toxics. 10: PMID: 35736888
- Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. | Cassileth, PA., et al. 1983. Arch Intern Med. 143: 1347-9. PMID: 6347109
- Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days. | Hagan, RL., et al. 1996. Am J Health Syst Pharm. 53: 1431-5. PMID: 8781690
Activator of:
Calponin 1, CD16-A, GR, IgG2a, and IL-17REL.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Dexamethasone Sodium Phosphate, 100 mg | sc-204715 | 100 mg | $55.00 | |||
Dexamethasone Sodium Phosphate, 500 mg | sc-204715A | 500 mg | $158.00 |